Insider Transactions in Q3 2023 at Anaptysbio, Inc (ANAB)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,895
-80.16%
|
$74,005
$19.32 P/Share
|
|
Sep 18
2023
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,895
-81.54%
|
$74,005
$19.32 P/Share
|
|
Sep 14
2023
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,105
-24.39%
|
$39,995
$19.48 P/Share
|
|
Sep 14
2023
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+41.01%
|
-
|
|
Sep 14
2023
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,105
-30.23%
|
$39,995
$19.48 P/Share
|
|
Sep 14
2023
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+46.28%
|
-
|
|
Sep 14
2023
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,105
-30.59%
|
$39,995
$19.48 P/Share
|
|
Sep 14
2023
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+46.58%
|
-
|